Overview of Dr. Ocean
Dr. Allyson Ocean is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Tufts University School of Medicine and has been in practice 19 years. Dr. Ocean accepts several types of health insurance, listed below. She is one of 368 doctors at New York-Presbyterian Hospital and one of 115 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 100 publications and over 500 citings.
Office
1305 York Avenue
12th Floor
New York, NY 10021- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2001 - 2004
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2001
- Tufts University School of MedicineClass of 1998
- George Mason UniversityNo Degree, Pre-medical coursework, 1993 - 1994
- Tufts UniversityBA, International Relations, Cum Laude, 1989 - 1993
- Institute of European StudiesNo Degree, 1991 - 1992
Certifications & Licensure
- NY State Medical License 1999 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Anne Moore, M.D. Clinical Scholar Award in Gastrointestinal Oncology 2010
- Grant Award Recipient Advanced Research Foundation, 2009
- Join now to see all
Clinical Trials
- Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach Start of enrollment: 2003 Apr 01
- Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer Start of enrollment: 2003 Nov 01
- Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer Start of enrollment: 2004 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsA Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pa...Nicolette J Rodriguez, C Sloane Furniss, Matthew B Yurgelun, Chinedu Ukaegbu, Pamela E Constantinou, Ileana Fortes, Alyson Caruso, Alison N Schwartz, Jill E Stopfer, M...> ;Gastroenterology. 2024 May 1
- 3 citationsNeoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.Pashtoon Murtaza Kasi, Manuel Hidalgo, Mehraneh D Jafari, Heather Yeo, Lea Lowenfeld, Uqba Khan, Alana T H Nguyen, Despina Siolas, Brandon Swed, Jini Hyun, Sahrish Kha...> ;Oncogene. 2023 Oct 1
- Giving information strategically and transparently: A pilot trial of the Oncolo-GIST intervention to promote patients' prognostic understanding.Holly G Prigerson, David Russell, Sophia E Kakarala, Heather M Derry-Vick, Manish A Shah, Ashish Saxena, Valerie F Reyna, Allyson Ocean, Ronald Scheff, Paul K Maciejew...> ;Cancer Medicine. 2023 Sep 1
- Join now to see all
Journal Articles
- Phase II trial of bortezomib alone or in combinationwith irinotecan in patients with adenocarcinomaof the gastroesophageal junction or stomachAllyson J. Ocean, Paul Christos, Joseph A. Sparano, Manish A. Shah, Rhonda K. Yantiss, Jonathan Cheng , Juan Lin, Michael Papetti, Dan Matulich, Felice Schnoll-Sussman..., Invest New Drugs, 1/1/2014
- Fractionated Radioimmunotherapy (RAIT) With 90Y-Clivatuzumab Tetraxetan (90Y-hPAM4) And Low-dose Gemcitabine Is Active In Advanced Pancreatic Cancer: A Phase I trialAllyson J. Ocean, MD; Kenneth L. Pennington, MD; Michael J. Guarino, MD; Arif Sheikh, MD; Tanios Bekaii-Saab, MD; Aldo N. Serafini, MD; Daniel Lee, MD; Max W. Sung, MD..., Cancer, 1/8/2012
- Peripheral neuropathy with microtubule-targeting agents: occurrence and management approachCarlson K, Ocean AJ, Clinical Breast Cancer, 1/1/2011
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Phase I/II trial of intraperitoneal implantation of agarose-agarosemacrobeads (MB) containing mouse renal adenocarcinoma cells (RENCA) in patients (pts) with advanced ...Allyson J. Ocean, Tapan Parikh, Nathaniel Berman, Juliet Escalon, Manish A. Shah, Zoe Andrada, Eugene Akahoho, Janice M. Pogoda, George B. Stoms, Verula B Escobia, Jos..., J Clin Oncol, 1/1/2013
- Effect of CTCAE v4 grading of hypertension on reported toxicity in advanced cancer patients receiving vascular endothelial growth factor (VEGF)-targeting agents.Naveed Hassan Akhtar, Beerinder Singh, Allyson J. Ocean, Irene Karpenko, Himisha Beltran, Elizabeta C. Popa, David M. Nanus, Manish A. Shah, Scott T. Tagawa, J Clin Oncol, 1/1/2013
- The incidence and impact of poor nutrition in gastrointestinal malignancies.Douglas Eric Guggenheim, Allyson J. Ocean, Elizabeta C. Popa, Amanda R Magli, Irene Karpenko, Paul J. Christos, Veronica A. Rosales, Erika Ocampo Florendo, Joseph T. R..., J Clin Oncol, 1/1/2013
- Join now to see all
Lectures
- “Current Standard and Experimental Treatments in Pancreatic Cancer: Chemotherapy and Targeted Therapies.”1/19/2011
- “Early Stage Colorectal Cancer: Reducing Risk of Recurrence.”New York Presbyterian Hospital-Columbia - 1/13/2011
- “ClivatuzumabTetraxetan for the Therapy of Patients with Pancreatic Cancer.”New York City, NY - 1/15/2010
- Join now to see all
Other
- Good Morning America presentationOcean AJ
http://abcnews.go.com/video/playerIndex?id=7167408
1/25/2009 - Larry King Live presentationOcean AJ
http://www.cnn.com/video/#/video/health/2009/05/19/lkl.farrahs.story.long.cnn?iref=videosearch
1/19/2009 - “What makes pancreatic cancer so deadly?”, Online InterviewOcean AJ, The Scientific American
1/25/2008 - Join now to see all
Press Mentions
- No Longer a Death Sentence: New Treatments for Pancreatic Cancer Offer Patients HopeMay 20th, 2023
- Study of SM-88 Shows Promising Results in Advanced Pancreatic CancerAugust 4th, 2019
- TYME Presents Updated Data at ESMO GI 2019 from TYME-88-Panc Phase II Study Demonstrating Encouraging Overall Survival Trends in Patients with Advanced Pancreatic CancerJuly 8th, 2019
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- New York-Presbyterian HospitalNew York, New York
- New York-Presbyterian HospitalNew York, New York
- NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPOGreat West PPO
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: